Logo

Abbott Launches Amplatzer Steerable Delivery Sheath for Amulet Device to Treat Atrial Fibrillation

Share this
Abbott Launches Amplatzer Steerable Delivery Sheath for Amulet Device to Treat Atrial Fibrillation

Abbott Launches Amplatzer Steerable Delivery Sheath for Amulet Device to Treat Atrial Fibrillation

Shots:

  • The company reported the commercial availability of Amplatzer steerable delivery sheath to provide precise & flexible placement when used with Amplatzer Amulet LAA Occluder. The device will use dual-seal technology to seal LAA & reduce the risk of stroke & eliminates the need for blood-thinning medication
  • The Amplatzer steerable delivery sheath has bi-directional steering & auto-lock feature to provide better flexibility & accurate positioning when placing Amplatzer Amulet
  • The Amulet IDE trial showed that the device offers superior LAA closure @45 days & 12mos. The Amplatzer Amulet device received CE Mark in 2013 & was approved for use in 80+ countries

Ref: Abbott | Image: Abbott

Click here to­ read the full press release 

Neha

Neha Madan is a content writer at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions